'Discrepancies' Alleged in C-CURE Heart Failure Study Medscape LONDON, UK and AALST, BELGIUM — In a letter to the editors of the Journal of the American College of Cardiology (JACC), researchers take a deep dive into the specifics of the Cardiopoietic Stem Cell Therapy in Heart Failure (C-CURE) trial, questioning ... |
